Aussie imaging agent to help brain cancer patients
The United States Food and Drug Administration has approved Telix Pharmaceutical's Pixclara, an imaging agent to aid in the diagnosis of brain cancer.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.perthnow.com.au — the content belongs to PerthNow.
